Skip Navigation

European Heart Journal 1991 12(Supplement F):121-123; doi:10.1093/eurheartj/12.suppl_F.121
Copyright © 1991 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Richardt, G.
Right arrow Articles by Schömig, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richardt, G.
Right arrow Articles by Schömig, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1991 The European Society of Cardiology

Effect of angiotensin converting enzyme inhibitors on cardiac noradrenaline release

G. Richardt, R. Kranzhöfer and A. Schömig

From the Department of Cardiology, University of Heidelberg W-6900 Heidelberg, Germany

Correspondence: Dr. Gert Richardt, Department of Cardiology, University of Heidelberg, Bergheimer StraBe 58, W-6900 Heidelberg, Germany

Angiotensin II facilitates sympathetic transmitter release in the heart. Thus, angiotensin converting enzyme inhibitors may be assumed to suppress noradrenaline release in the heart.

To test this hypothesis endogenous noradrenaline release was induced either by electrical stimulation of the stellate ganglion or by global ischaemia in rat hearts. Noradrenaline was determined by high performance liquid chromatography in coronary venous overflow. Endogenous angiotensin formation was blocked by the angiotensin converting enzyme inhibitors captopril and ramiprilat and the activity of the endogenous renin-angiotensin system was modulated by variations in nutritional sodium load prior to the experiments.

Both angiotensin converting enzyme inhibitors significantly reduced noradrenaline release evoked by nerve stimulation when the animals had been fed a low sodium diet. Following a high sodium diet, however, captopril and ramiprilat had no effect on stimulation-induced noradrenaline release.

Global ischaemia (20min) resulted in noradrenaline overflow from sympathetic nerves, independent of nerve stimulation. This ischaemia-induced noradrenaline release was not influenced by either converting enzyme inhibitor.

In conclusion, the results suggest a sodium-dependent endogenous angiotensin formation in the heart which facilitates physiological noradrenaline release and is sensitive to angiotensin converting enzyme inhibitors. In contrast, noradrenaline release in ischaemia is not affected by converting enzyme blockers, due to a different, non-exocytotic release mechanism of noradrenaline during myocardial ischaemia.

Key Words: Angiotensin converting enzyme inhibitors • myocardial ischaemia, • noradrenaline release • sodium balance • rat heart • sympathetic stimulation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.